Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 73.80
-2.20 (-2.89%)
Oct 22, 2026, 2:39 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 114.79 billion as of October 23, 2026. It is the 4,602nd most valuable company in the world and the 131st biggest in Taiwan. Its market cap has decreased by 54.87% in one year.
Market Cap
114.79B
Enterprise Value
110.85B
Revenue
29.39M
Global Rank
Country Rank
#131 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 114.79B, an increase of 1,342.35%. That is a compound annual growth rate of 100.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 114.79B | -52.22% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 134.75B |
| Pell Bio-Med Technology | 49.40B |
| Oneness Biotech | 23.09B |
| CHO Pharma | 23.01B |
| Sunmax Biotechnology | 21.54B |
| Medigen Vaccine Biologics | 16.77B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.31B |